Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$335,791,005
+$25,521,603 QoQ
Shares Held
1,322,168
+4.2% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#136
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. JNJ ranks #2 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
544,998 | $653,687,004 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,322,168 | $335,791,005 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,264,357 | $245,712,249 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,644,035 | $207,707,380 | |
| 5 | PFE |
Pfizer Inc
|
8,327,265 | $200,520,541 | |
| 6 | ABBV |
AbbVie Inc.
|
672,932 | $169,336,607 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,131,286 | $145,370,250 | |
| 8 | AMGN |
Amgen Inc
|
382,676 | $138,574,632 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,791,005 | 1,322,168 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $310,269,402 | 1,269,307 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $475,329,174 | 2,296,831 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $349,722,700 | 1,886,111 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $148,862,817 | 974,552 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $65,680,931 | 396,050 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $131,300,787 | 907,902 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $149,864,012 | 924,744 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $187,330,786 | 1,281,683 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $146,352,167 | 925,167 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $281,387,954 | 1,795,253 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $309,347,379 | 1,986,179 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $324,172,078 | 1,958,507 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $231,616,500 | 1,494,300 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $293,142,019 | 1,659,451 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $191,703,449 | 1,173,503 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $212,116,639 | 1,194,956 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $227,588,309 | 1,284,141 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $260,978,575 | 1,525,566 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $213,323,250 | 1,320,887 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $172,072,247 | 1,044,508 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $167,101,712 | 1,016,743 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $171,946,778 | 1,092,558 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $122,796,521 | 824,802 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $137,881,667 | 980,457 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $90,170,756 | 687,644 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||